Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Corcept Therapeutics (CORT) Interest Coverage Ratio (2016 - 2017)

Corcept Therapeutics (CORT) has disclosed Interest Coverage Ratio for 7 consecutive years, with 130.56 as the latest value for Q2 2017.

  • Quarterly Interest Coverage Ratio rose 4497.35% to 130.56 in Q2 2017 from the year-ago period, while the trailing twelve-month figure was 705.2 through Mar 2018, up 8036.4% year-over-year, with the annual reading at 4.99 for FY2016, 529.91% up from the prior year.
  • Interest Coverage Ratio hit 130.56 in Q2 2017 for Corcept Therapeutics, up from 21.07 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 130.56 in Q2 2017 to a low of 12.01 in Q1 2014.
  • Historically, Interest Coverage Ratio has averaged 6.47 across 5 years, with a median of 1.51 in 2015.
  • Biggest five-year swings in Interest Coverage Ratio: decreased 25.19% in 2014 and later surged 4497.35% in 2017.
  • Year by year, Interest Coverage Ratio stood at 9.17 in 2013, then skyrocketed by 58.97% to 3.76 in 2014, then soared by 163.43% to 2.39 in 2015, then surged by 411.86% to 12.21 in 2016, then skyrocketed by 969.11% to 130.56 in 2017.
  • Business Quant data shows Interest Coverage Ratio for CORT at 130.56 in Q2 2017, 21.07 in Q1 2017, and 12.21 in Q4 2016.